Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Associations between epidermal growth factor receptor gene mutation and serum tumor markers in advanced lung adenocarcinomas: a retrospective study.

Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih - 1 Sept 2014

Pan Ying-qiu, Shi Wei-wu, Xu Dan-ping, Xu Hui-hui, Zhou Mei-ying, Yan Wei-hua

Abstract excerpt

OBJECTIVE: To investigate the associations between epidermal growth factor receptor (EGFR) gene mutations and serum tumor markers in advanced lung adenocarcinomas. METHODS: We investigated the association between EGFR gene mutations and clinical features, including serum tumor marker levels, in 97 advanced lung adenocarcinomas patients who did not undergo the treatment of EGFR tyrosine kinase inhibitors. EGFR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to EGFR gene

Share to Lung Neoplasms

Share to Mutation

Share to Real-Time Polymerase Chain Reaction

Share to ROC Curve

Source

Identifiers

PMID: 25264883
DOI: 10.1016/s1001-9294(14)60061-4

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations between epidermal growth factor receptor gene mutation and serum tumor markers in advanced lung adenocarcinomas: a retrospective study.PMID 25264883Read ↗

Correlation between EGFR mutations and serum tumor markers in lung adenocarcinoma patients.Semantic proximity Read ↗

The relationship between EGFR mutation status and clinic-pathologic features in pulmonary adenocarcinoma.Semantic proximity Read ↗

Can serum be used for analyzing the EGFR mutation status in patients with advanced non-small cell lung cancer?Semantic proximity Read ↗

Correlation between serum CEA levels and EGFR mutations in Chinese nonsmokers with lung adenocarcinoma.Semantic proximity Read ↗

The correlation between pre-treatment CEA levels and the EGFR mutation status in advanced lung adenocarcinoma.Semantic proximity Read ↗

Association between serum CEA levels and ctDNA-detected Epidermal Growth Factor Receptor mutations in lung adenocarcinomaSemantic proximity Read ↗

Comparison of EGFR mutation rates in lung adenocarcinoma tissue and pleural effusion samples.Semantic proximity Read ↗

Correlation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinoma.Semantic proximity Read ↗

Limitations in the Use of Serum Epidermal Growth Factor Receptor Mutations as Prognostic Markers for Non-Small-Cell Lung Cancer.Semantic proximity Read ↗

Should EGFR mutations be tested in advanced lung squamous cell carcinomas to guide frontline treatment?Semantic proximity Read ↗

Clinical and pathological characteristics of EGFR mutation in operable early-stage lung adenocarcinomaSemantic proximity Read ↗

Monitoring of carcinoembryonic antigen levels is predictive of EGFR mutations and efficacy of EGFR-TKI in patients with lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.